Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/1993
11/02/1993CA1323833C Pharmaceutical compositions in the form of beadlets and method
11/02/1993CA1323831C Solubilization of salts of pyridine-2-thiol-1-oxide
10/1993
10/31/1993CA2095206A1 4- or 5-(sulf)imido- and -(sulfon)amidopyridines and their pyridine n-oxides, processes for their preparation, and their use as medicaments
10/29/1993CA2095086A1 Piroxicam tablets and production process thereof
10/29/1993CA2095009A1 Cyclic imino derivatives
10/29/1993CA2094964A1 Cyclic imino derivatives
10/29/1993CA2094963A1 Labelled fibrinogen receptor antagonists, the use thereof and processes for preparing them
10/29/1993CA2094962A1 Azole compounds, their production and use
10/29/1993CA2094341A1 Methods for the use of spermidine/spermine n1-acetyltransferase as a prognostic indicator and/or tumor response marker
10/28/1993WO1993021304A1 Method for the inhibition of the proliferation of cancer cells in a tumor
10/28/1993WO1993021252A1 Synthetic melanin
10/28/1993WO1993021225A1 Synthetic peptide, pulmonary surfactant containing the same, and remedy for respiratory distress syndrome
10/28/1993WO1993021202A1 Synthetic antisense oligodeoxynucleotides and pharmaceutical compositions containing them
10/28/1993WO1993021199A1 5-o-desosaminylerythronolide a derivative
10/28/1993WO1993021198A1 Novel sialylsteroid
10/28/1993WO1993021195A1 Water-soluble retinoids
10/28/1993WO1993021193A1 Platinum complex and antineoplastic agent
10/28/1993WO1993021188A1 Delta opioid receptor-selective benzylidene-substituted morphinans for the treatment of alcohol abuse
10/28/1993WO1993021187A1 7-DISUBSTITUTED-METHYL-4-OXO-3H^_,5H^_-PYRROLO[3,2-d^_]PYRIMIDINE AND PHARMACEUTICAL USES AND COMPOSITIONS CONTAINING THE SAME
10/28/1993WO1993021186A1 Substituted 3-pyrrolidinylthio-carbapenems as antimicrobial agents
10/28/1993WO1993021185A1 Substituted nitrogen containing spiro compounds for use in treating cognitive deficits
10/28/1993WO1993021184A1 Biphenylylquinuclidine derivatives as squalene synthase inhibitors
10/28/1993WO1993021183A1 Quinuclidine derivatives as squalene synthase inhibitors
10/28/1993WO1993021182A1 Heteroaromatic 5-hydroxytryptamine receptor agonists
10/28/1993WO1993021181A1 Azacyclic compounds
10/28/1993WO1993021180A1 Acylaminoindole derivatives as 5-ht1 agonists
10/28/1993WO1993021179A1 Novel amidoalkyl- and imidoalkyl-piperazines
10/28/1993WO1993021178A1 Indole derivatives as 5-ht1-like agonists
10/28/1993WO1993021177A1 Indole derivatives as 5-ht1-like agonists
10/28/1993WO1993021173A1 Taxol derivatives
10/28/1993WO1993021172A1 Basic derivatives of glutamic acid and aspartic acid as gastrin or cholecystokinin antagonists
10/28/1993WO1993021171A1 Use of 2h-1,2,4-benzothiadiazine-1,1-dioxide-3-carboxylic acid derivatives for preparing nmda/ampa receptor antagonist drugs, novel products, preparation thereof and drugs containing same
10/28/1993WO1993021170A1 3,4-dihydro-2h-1,2,4-benzothiadiazine-1,1-dioxide-3-carboxylic acid derivatives, preparation thereof and drugs containing same
10/28/1993WO1993021166A1 Heterocyclic compounds and their use in the treatment of type ii-diabetes
10/28/1993WO1993021159A1 Quinoline derivatives as leukotriene antagonists
10/28/1993WO1993021158A1 Pyridine-substituted benzyl alcohols as leukotriene antagonists
10/28/1993WO1993021155A1 Perhydroisoindole derivatives as p substance antagonists
10/28/1993WO1993021153A1 Indole-2-carboxylic acid derivatives
10/28/1993WO1993021149A1 Phenyl substituted cycloalkyl hydroxyurea derivatives which inhibit lipoxygenase
10/28/1993WO1993021147A1 Method of administering pyruvate and methods of synthesizing pyruvate precursors
10/28/1993WO1993021146A1 Compounds having selectivity for retinoid x receptors
10/28/1993WO1993020850A1 Pharmaceutical composition
10/28/1993WO1993020847A1 Vaccine adjuvant
10/28/1993WO1993020839A2 Use of renin-angiotensin antagonist for reducing post myocardial infarct mobidity and mortality
10/28/1993WO1993020829A1 Methods for retarding blister formation by use of cyanoacrylate adhesives
10/28/1993WO1993020828A1 Methods for the multiple, intermittent, non-sterile use of cyanoacrylate adhesives
10/28/1993WO1993020827A1 Preparations of low molecular weight hyaluronic acid for stimulating bone formation
10/28/1993WO1993020826A1 Pharmaceutical composition
10/28/1993WO1993020825A1 Method of treating cancer by conjunctive therapy with 2'-halomethylidene derivatives and an s-phase or m-phase specific antineoplastic agent
10/28/1993WO1993020824A1 Pharmaceutical compositions containing monosialoganglioside derivatives suitable for the treatment of spinal cord injury
10/28/1993WO1993020823A1 Ocular androgen therapy in sjögren's syndrome
10/28/1993WO1993020822A1 Compositions of platelet activating factor antagonists and methods of treating interleukin-2 induced lung injury therewith
10/28/1993WO1993020821A1 Agents for treating substance abuse disorders
10/28/1993WO1993020819A1 Treatment of delayed gastric emptying
10/28/1993WO1993020818A1 SUBSTITUTED INDOLIZINO[1,2-b]QUINOLINONES
10/28/1993WO1993020817A1 Novel use of nitroimidazoles
10/28/1993WO1993020816A1 Angiotensin ii antagonists against disorders associated with impaired neuronal conduction velocity, especially diabetic neuropathy
10/28/1993WO1993020815A1 Use of h-2 antagonists for treatment of gingivitis
10/28/1993WO1993020814A1 Immuno-activating and hence anti-viral effect of 4-[3-(subst.-amino)-2-hydroxypropoxy]-1,2,5-thiadiazole compounds
10/28/1993WO1993020813A1 1,3,-propanediamine derivatives having protein kinase c inhibitory activity
10/28/1993WO1993020812A1 Potentiation of antimicrobial effects
10/28/1993WO1993020811A1 Therapeutic cholesterol gallstone dissolution method
10/28/1993WO1993020810A2 Photochemotherapeutic method using 5-aminolevulinic acid and precursors thereof
10/28/1993WO1993020809A1 Arylalkanoic acid s enantiomer for reducing adverse side effects
10/28/1993WO1993020808A1 Aminoguanidine spray drying process
10/28/1993WO1993020807A1 Amines as inhibitors of squalene synthase
10/28/1993WO1993020806A1 Use of nitric oxide/nucleophile complexes for the treatment of cancer
10/28/1993WO1993020805A1 Chemical prevention or reversal of cataract by phase separation inhibitors
10/28/1993WO1993020804A1 Psychoactive propargylamine derivatives
10/28/1993WO1993020798A1 Oral suspension formulation
10/28/1993WO1993020796A1 Method and composition for treating acne
10/28/1993WO1993020718A1 Food composition which inhibits formation of intestinal putrefaction product
10/28/1993WO1993020696A1 Regulation of the immune system
10/28/1993WO1993019024A3 Mercapto-acetamide derivatives
10/28/1993WO1993018762A3 Method for reducing intraocular pressure in the mammalian eye by administration of gamma aminobutyric acid (gaba) agonists
10/28/1993WO1993018173A3 Cd4 binding agents and inhibitors of collagenase and protein kinase c
10/28/1993WO1993009222A3 Transfection of vertebrate cells e.g. by homologous recombination
10/28/1993DE4213338A1 Treatment of impotence
10/28/1993DE4213175A1 Compsns. for treating ketosis, esp. in ruminants, by oral admin. - contains glycerol as glucose biosynthesis precursor
10/28/1993DE4213167A1 Medicament against gastritis, stomach and duodenal ulcers, and dyspepsia - contg. thymol, carvacol, cymol or cineol as extract of thyme to destroy Helicobacter pylori
10/28/1993DE4213064A1 Theophylline recovery from tabletting dust - by extraction with aq. ammonia, used as diuretic
10/28/1993CA2133840A1 Perhydroisoindole derivatives used as p substance antagonists
10/28/1993CA2133754A1 Compositions of platelet activating factor antagonists and methods of treating interleukin-2 induced lung injury therewith
10/28/1993CA2133727A1 Chemical prevention or reversal of cataract by phase separation inhibitors
10/28/1993CA2133346A1 7-disubstituted-methyl-4-oxo-3h,5h-pyrrolo¬3,2-d|pyrimidine and pharmaceutical uses and compositions containing the same
10/28/1993CA2133078A1 Heteroaromatic 5-hydroxytryptamine receptor agonists
10/28/1993CA2133077A1 Azacyclic compounds
10/28/1993CA2132723A1 Pyridine-substituted benzyl alcohols as leukotriene antagonists
10/28/1993CA2130578A1 Taxol derivatives
10/28/1993CA2130198A1 Method of administering pyruvate and methods of synthesizing pyruvate precursors
10/28/1993CA2130096A1 3,4-dihydro-2h-1,2,4-benzothiadiazine-1,1-dioxide-3-carboxylic acid derivatives; process for preparing the same and therapeutic agents containing them
10/28/1993CA2130095A1 2h-1,2,4-benzothiadiazine-1,1-dioxide-3-carboxylic acid derivatives used for preparing therapeutic compounds; new products obtained; process for preparing them and therapeutic agents containing the same
10/28/1993CA2118324A1 Substituted indolizino¬1,2-b|quinolinones
10/28/1993CA2118217A1 Platinum complex and antitumor agent
10/28/1993CA2118212A1 Substituted nitrogen containing spiro compounds for use in treating cognitive deficits
10/28/1993CA2118023A1 Regulation of the immune system using androstene compounds
10/28/1993CA2117899A1 Substituted 3-pyrrolidinylthio-carbapenems as antimicrobial agents
10/28/1993CA2117762A1 Pharmaceutical composition
10/28/1993CA2117498A1 Indole derivatives as 5-ht1-like agonists
10/28/1993CA2111581A1 Immunoactivating and therefore antiviral effect of 4-[3-(subst.-amino)-2-hydroxypropoxy]-1,2,5-thiadiazole- compounds
1 ... 7155 7156 7157 7158 7159 7160 7161 7162 7163 7164 7165 7166 7167 7168 7169 7170 7171 7172 7173 7174 7175 ... 7860